Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.

Last updated on 2022-10-18 History
Report ID 147717
Drug Identification Number 02173360
Brand name TEVA-SALBUTAMOL STERINEBS P.F.
Common or Proper name SALBUTAMOL 2MG/ML NEBS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 2.5ml
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-10-20
Estimated end date 2022-10-20
Actual end date 2022-10-17
Shortage status Resolved
Updated date 2022-10-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2022-10-18 English Compare
v24 2022-10-17 French Compare
v23 2022-10-17 English Compare
v22 2022-09-30 French Compare
v21 2022-09-30 English Compare
v20 2022-09-22 French Compare
v19 2022-09-22 English Compare
v18 2022-09-07 French Compare
v17 2022-09-07 English Compare
v16 2022-06-16 French Compare
v15 2022-06-16 English Compare
v14 2022-06-03 French Compare
v13 2022-06-03 English Compare
v12 2022-04-21 French Compare
v11 2022-04-21 English Compare
v10 2022-04-08 French Compare
v9 2022-04-08 English Compare
v8 2022-02-17 French Compare
v7 2022-02-17 English Compare
v6 2022-01-20 French Compare

Showing 1 to 20 of 25